CA Stock MarketDetailed Quotes
QPT Quest PharmaTech Inc
- 0.020
- +0.005+33.33%
15min DelayMarket Closed Aug 16 16:00 ET
3.38MMarket Cap-869P/E (TTM)
0.030High0.020Low163.64KVolume0.030Open0.015Pre Close4.32KTurnover0.07052wk High0.12%Turnover Ratio169.13MShares0.01552wk Low-0.023EPS TTM2.77MFloat Cap0.462Historical HighLossP/E (Static)138.75MShs Float0.010Historical Low-0.018EPS LYR66.67%Amplitude--Dividend TTM0.15P/B1Lot Size--Div YieldTTM
Quest PharmaTech Inc Key Stats
Quarterly+Annual
YOY
| (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | (Q3)Oct 31, 2023 | (Q2)Jul 31, 2023 | (Q1)Apr 30, 2023 | (FY)Jan 31, 2023 | (Q4)Jan 31, 2023 | (Q3)Oct 31, 2022 | (Q2)Jul 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -155.67%-210.99K | 38.27%-342.42K | 68.68%-61.72K | 86.86%-7.5K | 22.03%-189.19K | -42.48%-82.52K | -224.80%-554.68K | -508.63%-197.05K | -62.47%-57.06K | -94.20%-242.66K |
| Net income from continuing operations | -705.53%-861.33K | 95.35%-3.02M | 123.24%14.48M | -175.63%-2.51M | -1,498.50%-9.82M | 89.80%-106.93K | 23.70%-64.89M | 17.87%-62.31M | 89.91%-911.13K | -236.79%-614.03K |
| Operating gains losses | 1,297.82%755.58K | -97.12%1.85M | -97.40%1.62M | -44.91%597.99K | -198.68%-298.82K | -106.49%-63.08K | -23.78%64.39M | -18.11%62.03M | -87.93%1.09M | 138.13%302.82K |
| Depreciation and amortization | --0 | -77.96%2.97K | --0 | --0 | -24.56%2.54K | -95.48%429 | -65.03%13.49K | -96.73%312 | -96.79%311 | -65.16%3.37K |
| Remuneration paid in stock | ---- | --100K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Unrealized gains and losses of investment securities | --57.9K | ---- | ---- | --1.75M | --9.64M | --0 | ---- | ---- | --0 | --0 |
| Remuneration paid in stock | ---- | 208.19%471.53K | --51.53K | --0 | 233.33%420K | ---- | -43.44%153K | --0 | --0 | -53.42%126K |
| Other non cashItems | ---- | ---- | ---- | --10.42K | ---- | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | -287.39%-163.13K | 210.65%249.21K | 81.20%154.33K | 162.23%144.17K | -131.35%-140.71K | 586.66%87.05K | -374.50%-225.23K | 17.19%85.17K | -5,248.34%-231.69K | -1.57%-60.82K |
| -Change in receivables | --0 | 109.64%21.31K | ---- | ---- | ---- | 154.81%1.99K | -781.86%-220.99K | ---- | ---- | ---- |
| -Change in prepaid assets | 217.89%6.94K | 664.42%11.53K | ---- | ---- | ---- | -161.18%-5.89K | -107.82%-2.04K | ---- | ---- | ---- |
| -Change in payables and accrued expense | -286.99%-170.08K | 9,966.44%216.37K | ---- | ---- | ---- | 480.72%90.96K | -109.32%-2.19K | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -155.67%-210.99K | 38.27%-342.42K | 68.68%-61.72K | 86.86%-7.5K | 22.03%-189.19K | -42.48%-82.52K | -224.80%-554.68K | -508.63%-197.05K | -62.47%-57.06K | -94.20%-242.66K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | 0 | 0 | 85.82%-1.49K | -0.01%-14K | -100.01%-1 | 0 | 64.80%-3.53K |
| Net PPE purchase and sale | --0 | ---- | ---- | ---- | ---- | ---1.49K | ---- | ---- | ---- | ---- |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | -0.01%-14K | -100.01%-1 | ---- | 64.80%-3.53K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --0 | --0 | --0 | 85.82%-1.49K | -0.01%-14K | -100.01%-1 | --0 | 64.80%-3.53K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0.84%684.72K | 660.80%684.72K | 0 | 200K | -135.15%-200K | 171.60%679K | -64.00%90K | 20K | 0 |
| Net issuance payments of debt | --0 | --0 | --0 | --0 | --200K | -140.00%-200K | 100.00%500K | --0 | --0 | --0 |
| Net common stock issuance | ---- | --0 | ---- | ---- | ---- | ---- | --90K | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | ---- | --0 | --0 | --0 | --0 | ---- | --89K | --0 | --20K | --0 |
| Net other financing activities | ---- | --684.72K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | 0.84%684.72K | 660.80%684.72K | --0 | --200K | -135.15%-200K | 171.60%679K | -64.00%90K | --20K | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 91.36%716.96K | 41.73%374.66K | -80.49%93.96K | -80.44%101.46K | -88.15%90.65K | 41.73%374.66K | 32.76%264.34K | 1,471.06%481.7K | 583.05%518.77K | 262.67%764.95K |
| Current changes in cash | 25.71%-210.99K | 210.29%342.31K | 681.99%623K | 79.77%-7.5K | 104.39%10.81K | -156.73%-284.01K | 69.13%110.32K | -145.81%-107.05K | 18.16%-37.06K | -82.40%-246.19K |
| End cash Position | 458.16%505.98K | 91.36%716.96K | 91.36%716.96K | -80.49%93.96K | -80.44%101.46K | -88.15%90.65K | 41.73%374.66K | 41.73%374.66K | 1,471.06%481.7K | 583.05%518.77K |
| Free cash from | -151.15%-210.99K | 38.27%-342.42K | 68.68%-61.72K | 86.86%-7.5K | 22.03%-189.19K | -45.05%-84.01K | -224.80%-554.68K | -508.63%-197.05K | -62.47%-57.06K | -94.20%-242.66K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg